SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

Broadcom ($AVGO) is trending amid discussions about AI infrastructure spending, potential partnerships, and upcoming earnings. Community members are debating the stock's valuation and potential for growth, with some highlighting analyst price target increases and the company's solid track record, while others express concern about a possible AI bubble. Also, Broadcom will release earnings on December 11th, which is influencing the stock price.

Novo Nordisk A/S is a global healthcare company, which engages in the discovery, development, manufacturing and marketing of pharmaceutical products. It operates through the Diabetes and Obesity Care, and Rare Disease segments. The Diabetes and Obesity Care segment includes diabetes, obesity, cardiovascular, and emerging therapy areas. The Rare Disease segment refers to rare blood disorders, rare endocrine disorders, and hormone replacement therapy. The company was founded by Harald Pedersen and Thorvald Pedersen in 1923 is headquartered in Bagsværd, Denmark.

Novo Nordisk - ADR

Novo Nordisk A/S

Novo Nordisk is trending downwards as investors react to the failed Alzheimer's trial for semaglutide, despite the company's claim that the trial was a long shot with limited expectations; the decline is exacerbated by concerns about increased competition and potential pricing pressures in the weight loss drug market, and some investors speculate about potential acquisitions as a strategy to regain market share, while others see the current price as a buying opportunity given the company's strong fundamentals and the anticipation of the oral Wegovy launch.

WeRide, Inc. operates as an investment holding company. It engages in the sale of autonomous driving vehicles, primarily including robobuses, robotaxis, robosweepers and related sensor suites. The company was founded by Tony Xu Han and Yan Li in February 2017 and is headquartered in Guangzhou, China.

WeRide Inc. - ADR

WRD is trending due to positive earnings reports and analysts recognizing its potential in the robotaxi sector, with a focus on L4 technology. The community is discussing the company's revenue growth, expansion into new markets like Abu Dhabi, and partnerships with Uber and Bosch. Optimism is building around the stock's long-term potential, with some eyeing it as a candidate for stock of the year.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

GOOG is trending as it hits new all-time highs, fueled by enthusiasm surrounding its Gemini 3 AI model and potential dominance in the AI space. Community members are actively discussing its valuation, market cap, and potential competition with other tech giants, with some pointing out its strong core business and AI capabilities. The stock's recent performance is leading to debates about whether it's overbought and due for a correction.

Jelly-My-Jelly

JELLYJELLY is trending amid community excitement over potential price appreciation, with some comparing it to other successful runners. However, there are also concerns about the sustainability of the rally and reports of suspicious wallet activity, alongside short positions being taken. The coin, associated with the Solana network, has seen significant volatility and liquidations.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company, which engages in the development of medicines that treat intractable diseases by silencing the genes that cause them. The firms preclinical stage drug candidates include ARO-ANG3, ARO-AAT, ARO-APOC3, ARO-HIF2, ARO-HSD, ARO-Lung2, ARO-COV, and ARO-ENaC. The company was founded by Robert Bruce Stewart in 1989 and is headquartered in Pasadena, CA.

Arrowhead Pharmaceuticals Inc.

Arrowhead Pharmaceuticals ($ARWR) is trending due to recent positive developments, including analyst upgrades and licensing deals, particularly the Novartis collaboration for a preclinical Parkinson's therapy. The community is focused on the potential for upcoming catalysts, such as the PDUFA date for Plozasiran and data readouts from other pipeline candidates, to drive significant market cap growth. Discussions also involve comparisons to Alnylam's valuation and the competitive landscape with Ionis Pharmaceuticals.

Ondas Holdings, Inc. engages in the development, marketing, and sale of wireless radio systems for secure, wide area mission-critical business-to-business networks. It operates through the Ondas Networks and Ondas Autonomous Systems segments. The Ondas Networks segment provides wireless connectivity solutions enabling mission-critical Industrial Internet applications and services. The Ondas Autonomous Systems segment designs, develops, and markets commercial drone solutions via the Optimus System and Scout System. The company was founded on December 22, 2014 and is headquartered in Boston, MA.

Ondas Holdings Inc

Ondas Holdings is trending amid news of a $35 million strategic investment in Performance Drone Works (PDW), a combat robotics manufacturer, boosting the company's autonomous defense capabilities. The community is discussing the potential for increased production and revenue, as well as Ondas's expanding reach in the defense sector. Some are speculating about the impact of this investment on Ondas's growth trajectory and potential for further gains.

Oscar Health, Inc. is a health insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is surging amidst reports of a potential two-year extension of Obamacare subsidies, sparking excitement among traders who believe this could revitalize the company's ACA-driven model. Community members are actively discussing the implications of the subsidy extension on signups and pricing, despite analysts' concerns about the company's profitability. The news has triggered a sector rally, raising questions about whether this is a genuine turnaround or merely a politically-charged boost.

Sanofi engages in the research, production, and distribution of pharmaceutical products. It operates through the Biopharma segment, which comprises commercial operations and research, development and production activities relating to the specialty care, general medicines and vaccines franchises plus support and corporate functions, for all geographical territories. The company was founded in 1973 and is headquartered in Paris, France.

Sanofi - ADR

Sanofi-Aventis

Sanofi-Aventis ($SNY) is trending amidst ongoing discussions about potential acquisitions, particularly in the MASH and obesity space, with Altimmune ($ALT) and Fractyl ($GUTS) being named as possible targets. Community chatter revolves around the credibility and interpretation of clinical data for various candidates, with some questioning data integrity and others defending positive trial outcomes. Speculation about Sanofi's strategic moves to expand its pipeline and compete with Novo Nordisk ($NVO) and Eli Lilly ($LLY) in the weight loss market is also fueling the conversation.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble is trending amid discussions of Tether's increased investment and commitments to the platform's advertising and cloud services, with the community actively speculating about a potential short squeeze. High short interest and Tether's growing stake are fueling anticipation for a year-end rally. The community is also discussing the potential for Rumble to become a major player in the cloud computing space.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

EA Series Trust - Alpha Architect International Quantitative Value ETF

Buying

Holding

Selling or trimming

Watching from the sidelines

What are you doing with Alphabet ($GOOGL) stock as it hits fresh all-time highs?

Current Price	$29.94
Prev Close	$29.92
Open	$29.61
Dividend Yield	N/A
50-Day Moving Average	$30.36
Beta	N/A
Avg. Volume	8,276.87
PE Ratio	N/A

52-Week High	$30.97
52-Week Low	$22.74
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A
Enterprise Value/EBITDA	N/A

IVAL
EA Series Trust - Alpha Architect International Quantitative Value ETF

Feed

News

Sentiment

Fundamentals

Info

Latest IVAL News

IVALEA Series Trust - Alpha Architect International Quantitative Value ETF